U.S. Markets closed

Could drug-price transparency raise prices? These lobbyists and lawmakers think so

Victor Reklaitis
Could drug-price transparency raise prices? These lobbyists and lawmakers think so

As Washington tries to respond to calls for lower drug prices, even efforts to just bring more transparency to the state of affairs aren’t a slam dunk.